ReMYND
- Biotech or pharma, therapeutic R&D
remynd is a clinical-stage biotech company located in Leuven (Belgium) and focused on developing small molecules for symptomatic and disease-modifying treatments of neurodegenerative disease. Our first-in-class AD program has entered Phase I.